• Saved

KRAS inhibitor-resistance in MET-amplified KRAS G12C non-small cell lung cancer induced by RAS- and non-RAS-mediated cell signaling mechanisms - PubMed

KRAS inhibitor-resistance in MET-amplified KRAS G12C non-small cell lung cancer induced by RAS- and non-RAS-mediated cell signaling mechanisms - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34365406/

doi: 10.1158/1078-0432.CCR-21-0856. Online ahead of print. 1 Department of Medical Oncology, Kindai University Faculty of Medicine. 2 Department of Medical Oncology, Kindai University Faculty of Medicine [email protected]. 3 Division of Cell Biology for Regenerative Medicine, Institute of Advanced Clinical Medicine, Kindai University.